Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Baupost Group and Biotie Therapies Corp.

Page 1 of 6

According to a recently-filed 13D, notorious investor Seth Klarman‘s Baupost Group currently owns a substantial position in the OTC stock Biotie Therapies Corp (OTCMKTS:BIOZF). The filing showed that Baupost owns 172.71 million shares of Biotie Therapies Corp, the activist position amassing over 17% of the company’s outstanding stock.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
The Baupost Group, L.L.C.04-3402144 0 172,711,112 0 172,711,112 172,711,112 17.1%
SAK Corporation04-3334541 0 172,711,112 0 172,711,112 172,711,112 17.1%
Seth A. Klarman 0 172,711,112 0 172,711,112 172,711,112 17.1%
Seth Klarman
Seth Klarman
Baupost Group

Page 1 of 6 SEC Filing



D.C. 20549


the Securities Exchange Act of 1934




Biotie Therapies Corp.

(Name of
Common Stock

(Title of
Class of Securities)

Seth A. Klarman,
The Baupost Group, L.L.C.
10 St. James Avenue, Suite 1700, 


Phone : (617) 210-8300

Address and Telephone Number of Person Authorized to Receive Notices and
January 19, 2016

(Date of
Event which Requires Filing of this Statement)

If the
filing person has previously filed a statement on Schedule 13G to report the
acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box.
Note: Schedules filed in paper
format shall include a signed original and five copies of the schedule,
including all exhibits. See §240.13d-7 for other parties to whom copies are to
be sent.

* The
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

information required on the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the
Page 1 of 6

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!